TEMN:SIXTemenos AG Analysis
Data as of 2026-05-28 - not real-time
CHF 65.70
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Temenos AG trades at CHF 65.7, well below its 20‑day (71.4), 50‑day (72.2) and 200‑day (71.2) moving averages, with RSI at 36.5 and a bearish MACD histogram, indicating short‑term weakness near the support level of CHF 64.3. However, the DCF‑derived fair value of CHF 135.9 and a trailing P/E of 20 versus an industry average of 41 suggest the stock is substantially undervalued, while a dividend yield of 2.15% and a payout ratio under 40% point to sustainable income.
Recent announcements of AI‑powered banking agents, a new cloud‑native core banking engagement with First Abu Dhabi Bank in Saudi Arabia, and expansion plans for the Canadian market reinforce growth momentum, complementing an 8.9% revenue growth, 74% gross margin and a stellar ROE of 53%. These fundamentals, combined with low beta and increasing volume, offset the high 30‑day volatility and elevated leverage, positioning Temenos as a compelling long‑term play.
Recent announcements of AI‑powered banking agents, a new cloud‑native core banking engagement with First Abu Dhabi Bank in Saudi Arabia, and expansion plans for the Canadian market reinforce growth momentum, complementing an 8.9% revenue growth, 74% gross margin and a stellar ROE of 53%. These fundamentals, combined with low beta and increasing volume, offset the high 30‑day volatility and elevated leverage, positioning Temenos as a compelling long‑term play.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above key support
- Bearish technical indicators (RSI, MACD)
- Attractive dividend yield
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant undervaluation vs DCF and peers
- Revenue growth and high profitability margins
- Strategic AI and cloud‑native product launches
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend and strong cash flow generation
- Low market beta reducing systematic risk
- Broad geographic footprint and expanding client base
Key Metrics & Analysis
Financial Health
Revenue Growth8.90%
Profit Margin26.21%
P/E Ratio20.0
ROE53.04%
ROA7.33%
Debt/Equity188.33
P/B Ratio11.6
Op. Cash FlowCHF359.6M
Free Cash FlowCHF531.5M
Industry P/E41.0
Technical Analysis
TrendNeutral
RSI36.5
SupportCHF 64.30
ResistanceCHF 78.05
MA 20CHF 71.42
MA 50CHF 72.24
MA 200CHF 71.22
MACDBearish
VolumeIncreasing
Fear & Greed Index93.48
Valuation
Fair ValueCHF 135.93
GradeUndervalued
TypeBlend
Dividend Yield2.15%
Risk Assessment
Beta0.32
Volatility43.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.